Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Tarquin4on Aug 15, 2017 12:46pm

240 Views

Post# 26583554

Today's Wall Street Journal Front Page

"Drug-Trial Previews Burn Investors"

"Shares might rise after a drugmaker reveals basic 'top line' results of a clinical trial--and then sink when full results are disclosed...or might sink on disappointing top-line results and rise if full results show unexpected benefits."

Possible stock manipulation by Roche insiders is also discussed.

Bullboard Posts

Gold vs. bitcoin, where should you invest?